![Non-natural ruthenium isotope ratios of the undeclared 2017 atmospheric release consistent with civilian nuclear activities | Nature Communications Non-natural ruthenium isotope ratios of the undeclared 2017 atmospheric release consistent with civilian nuclear activities | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-16316-3/MediaObjects/41467_2020_16316_Fig3_HTML.png)
Non-natural ruthenium isotope ratios of the undeclared 2017 atmospheric release consistent with civilian nuclear activities | Nature Communications
![SOLVED: Kuthenium-[06 ( IRu) is used t0 treat melanoma in the eye. This isotope decuys by p emSsiOH with half-life of 373.59 days Olle source of Ihe isope reprocessed nuclear mactor Iuel: SOLVED: Kuthenium-[06 ( IRu) is used t0 treat melanoma in the eye. This isotope decuys by p emSsiOH with half-life of 373.59 days Olle source of Ihe isope reprocessed nuclear mactor Iuel:](https://cdn.numerade.com/ask_images/eb15a3c4264b4ed39cd93a584d2b634f.jpg)
SOLVED: Kuthenium-[06 ( IRu) is used t0 treat melanoma in the eye. This isotope decuys by p emSsiOH with half-life of 373.59 days Olle source of Ihe isope reprocessed nuclear mactor Iuel:
![Airborne concentrations and chemical considerations of radioactive ruthenium from an undeclared major nuclear release in 2017 | PNAS Airborne concentrations and chemical considerations of radioactive ruthenium from an undeclared major nuclear release in 2017 | PNAS](https://www.pnas.org/cms/10.1073/pnas.1907571116/asset/01ac363c-22cc-4896-98e6-10558427bdf0/assets/graphic/pnas.1907571116fig01.jpeg)
Airborne concentrations and chemical considerations of radioactive ruthenium from an undeclared major nuclear release in 2017 | PNAS
![SOLVED: Ruthenium-106 (1O6Ru) is used to treat melanoma in the eye. This isotope decays by 8 emission with half-life of 373.59 days. One source of the isotope is reprocessed nuclear reactor fuel: SOLVED: Ruthenium-106 (1O6Ru) is used to treat melanoma in the eye. This isotope decays by 8 emission with half-life of 373.59 days. One source of the isotope is reprocessed nuclear reactor fuel:](https://cdn.numerade.com/ask_images/5b8ddaf28b974475b559a3ceeca36605.jpg)
SOLVED: Ruthenium-106 (1O6Ru) is used to treat melanoma in the eye. This isotope decays by 8 emission with half-life of 373.59 days. One source of the isotope is reprocessed nuclear reactor fuel:
![Non-natural ruthenium isotope ratios of the undeclared 2017 atmospheric release consistent with civilian nuclear activities | Nature Communications Non-natural ruthenium isotope ratios of the undeclared 2017 atmospheric release consistent with civilian nuclear activities | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-16316-3/MediaObjects/41467_2020_16316_Fig2_HTML.png)
Non-natural ruthenium isotope ratios of the undeclared 2017 atmospheric release consistent with civilian nuclear activities | Nature Communications
![SOLVED: Ruthenium-106 (!6Ru) is used to treat melanoma in the eye. This isotope decays by emission with a half-life of 373.59 days . One source of the isotope is reprocessed nuclear reactor SOLVED: Ruthenium-106 (!6Ru) is used to treat melanoma in the eye. This isotope decays by emission with a half-life of 373.59 days . One source of the isotope is reprocessed nuclear reactor](https://cdn.numerade.com/ask_previews/4a51076d-554f-4148-be37-03ce07aa1745_large.jpg)